Lilly asks FDA to not allow lone use of COVID-19 drug bamlanivimab
April 16 (Reuters) - Eli Lilly and Co said it had requested for cancellation of the U.S. authorization granted to its COVID-19 antibody, bamlanivimab,...
April 16 (Reuters) - Eli Lilly and Co said it had requested for cancellation of the U.S. authorization granted to its COVID-19 antibody, bamlanivimab,...